Bicyclic imidazo derivatives, a new class of highly selective inhibitors for the human immunodeficiency virus type 1.

doi:10.1016/0166-3542(94)90075-2

Paper

Bicyclic imidazo derivatives, a new class of highly selective inhibitors for the human immunodeficiency virus type 1.

Published Aug 1, 1994 · Christiane Moog, Alexander Wick, P. L. Ber

Antiviral research

Q1 SJR score

78

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Highly Cited

Study Snapshot

Bicyclic imidazo derivatives show potent inhibitory effects on HIV-1 replication, making them highly specific inhibitors of HIV-1 and not of HIV-2 or SIV.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Bicyclic imidazo derivatives, a new class of highly selective inhibitors for the human immunodeficiency virus type 1.

References

Citations